The AUA annual meeting is a remarkable gathering of international thought leaders, practitioners, and industry. As in past years, last month's event in Anaheim provided attendees not only with a measure of urology's scientific progress but also a barometer for many of the issues and concerns facing urologists in the trenches. Here is a very brief look at some of the science and trends that drew applause and raised eyebrows during the scientific sessions, on the exhibit floor, and behind closed doors.
Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.
Sandip M. Prasad, MD, MPhil, discusses the safety profile of mitomycin intravesical solution, including common adverse events and patient counseling during chemoablation for NMIBC.
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.